{
    "code": "12010275",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12010275",
    "time": "2020-02-26 02:16:10",
    "許可證字號": "內衛藥製字第010275號",
    "註銷狀態": "已註銷",
    "註銷日期": "99\/02\/08",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "102\/09\/30",
    "發證日期": "59\/09\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY01201027502",
    "中文品名": "博力多能注射液",
    "英文品名": "PREDRON INJECTION &quot;PRINCE&quot;",
    "適應症": "關節腱、粘液囊及神經鞘疾患、發炎、神經節及軟組織發炎、過敏性休克、伴有搔癢發炎之皮膚炎",
    "劑型": "270注射劑",
    "包裝": "安瓿 小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PREDNISOLONE PHOSPHATE SODIUM",
    "限制項目": "09委託製造",
    "申請商名稱": "0411802200  王子製藥股份有限公司",
    "申請商地址": "台北縣三重巿重新路三段１０７號９Ｆ",
    "主製造廠": [
        {
            "製造廠名稱": "1301605300  新東化學製藥股份有限公司",
            "製造廠廠址": "新竹巿中埔里牛埔路２４５號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804001540",
            "成分名稱": "PREDNISOLONE PHOSPHATE SODIUM",
            "含量描述": "10",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ]
}